EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $937 | $581 | $1,226 | $1,301 |
| G&A Expenses | $0 | $0 | $0 | $308 |
| SG&A Expenses | $1,069 | $1,235 | $1,660 | $1,312 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $554 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,006 | $1,816 | $2,885 | $2,613 |
| Operating Income | -$2,006 | -$1,654 | -$2,885 | -$2,613 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $114 | -$64 | $238 | -$66 |
| Pre-Tax Income | -$1,892 | -$1,718 | -$2,647 | -$2,679 |
| Tax Expense | $0 | -$168 | $0 | $0 |
| Net Income | -$1,892 | -$1,613 | -$2,647 | -$2,679 |
| % Margin | – | – | – | – |
| EPS | -0.016 | -0.014 | -0.023 | -0.059 |
| % Growth | -15.5% | 39.3% | 60.3% | – |
| EPS Diluted | -0.016 | -0.014 | -0.023 | -0.059 |
| Weighted Avg Shares Out | 115,101 | 113,271 | 113,271 | 45,432 |
| Weighted Avg Shares Out Dil | 115,101 | 113,271 | 113,271 | 45,432 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $166 | $0 |
| Interest Expense | $963 | $551 | $211 | $8 |
| Depreciation & Amortization | $0 | $168 | $228 | $2,613 |
| EBITDA | -$929 | -$999 | -$2,207 | -$0 |
| % Margin | – | – | – | – |